Author
@wliang wliang
grade Cx.com/wliang ↗
High-conviction retail AI-capex theme trader mapping megacaps down to micro-cap chokepoints
Posts a continuous bullish narrative around the AI/data-cent
trader score
-2.48
hit rate
30%
mean α
-1.90%
signals 14d
67
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 30% hit rate, -1.90% mean alpha, trader score -2.48. Their last-14d mentions, direction-adjusted, have moved -14.7% since posting (mean over 48 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-16 | BTC | @wliang | +0.60 | Remains bullish on crypto while Bitcoin consolidates above the referenced support zone. | · | tweet ↗ |
| 2026-10-15 | ZEC | @wliang | +0.15 | Expresses mild interest in an unexplained new ZEC chart feature. | · | tweet ↗ |
| 2026-10-15 | AAOI | @wliang | +0.65 | AAOI is testing weekly support where a prior test preceded a roughly 110% rally. | -19.4% | tweet ↗ |
| 2026-10-15 | CIFR | @wliang | +0.75 | Enter CIFR when the next blue-diamond signal appears. — States a concrete plan to enter CIFR on the next chart signal, with fundamentals unchanged. | -20.9% | tweet ↗ |
| 2026-10-15 | BTC | @wliang | +0.45 | Expects Bitcoin's heavy support zone to hold and suggests price may be near a bottom. | · | tweet ↗ |
| 2026-10-14 | PDSB | @wliang | +0.65 | Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups. | · | tweet ↗ |
| 2026-10-14 | IBRX | @wliang | +0.55 | Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups. | -17.1% | tweet ↗ |
| 2026-10-14 | ARKG | @wliang | +0.45 | Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups. | -0.2% | tweet ↗ |
| 2026-10-14 | ABCL | @wliang | +0.55 | Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups. | -4.4% | tweet ↗ |
| 2026-10-14 | MRNA | @wliang | +0.60 | Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups. | -11.6% | tweet ↗ |
| 2026-10-14 | QQQ | @wliang | +0.55 | High-beta dips are worth buying despite near-term volatility after the hot CPI report. — Explicitly recommends buying broad dips while viewing QQQ's higher-timeframe structure as intact. | -3.4% | tweet ↗ |
| 2026-10-13 | BTC | @wliang | +0.20 | Compares current Bitcoin consolidation with prior bases before rallies. | · | tweet ↗ |
| 2026-10-13 | CIFR | @wliang | +0.65 | Bullish CIFR setup identifies monthly support or a future indicator signal as possible entries. | -30.0% | tweet ↗ |
| 2026-10-13 | PDSB | @wliang | +0.80 | Explicitly bullish on PDSB's breakout and the broader biotech theme for Q4. | · | tweet ↗ |
| 2026-10-13 | IBRX | @wliang | +0.50 | Explicitly bullish on PDSB's breakout and the broader biotech theme for Q4. | -16.1% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.